Summary
The primary aims of the SOCQER-2 study are to describe any impact on short (6 weeks), medium term (6, 12 months) and long term (18 months, 24 months) PRO/quality of life using validated questionnaires in patients undergoing standard or extensive surgery for suspected or confirmed Stage III/IV ovarian cancer and to describe progression free survival (PFS) in these patients.
Key Facts
Lead Sponsor
Enrollment
Start Date
Completion Date
Study Type
Official Title
Interventions
Conditions
Eligibility
Age Range
Sex
Inclusion Criteria: * Patients with suspected or confirmed ovarian cancer with macroscopic spread beyond the pelvis (FIGO stage III-IV), determined through pre-operative clinical assessment or imaging * Patient listed for primary debulking surgery or neo-adjuvant chemotherapy with the intent of interval debulking surgery Exclusion Criteria: * Ovarian cancer relapse * Progression of cancer * Informed consent not obtained. * Primary chemotherapy with no intent of interval surgery * Actively receiving treatment for another cancer * Secondary cancers \<5years or relapsed secondary cancer in the past